Anti-angiogenic compounds
US8937048B2 · kind B2 · utility
1Cited by
11References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2012 |
| Grant date | Jan 20, 2015 |
| Priority date | — |
| Expiry date | Aug 27, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/71
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides various uses of VEGF binding peptides, including methods to treat disorders associated with abnormal angiogenesis. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.